Shanghai OPM Biosciences Co., Ltd.SSE: 688293

(688293)"SHANGHAI OPM BIOSCIENCES CO., LTD."Review Opinion and Statement on the Public Disclosure of the List of Participants for the Reserved Grant (First Batch) under the Company's 2026 Restricted Share and Share Appreciation Rights Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

· Issued by Shanghai OPM Biosciences Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688293 · · 3 pages · Chinese

Summary by 6ix AI

This filing is a review opinion and statement regarding the public disclosure of the list of participants for the reserved grant under the company's incentive plan. The document outlines the verification process and public announcement of the first batch of incentive recipients for the company's restricted stock and stock appreciation rights plan. The remuneration and appraisal committee confirmed that the listed participants meet the necessary qualifications and legal requirements for the incentive plan. No objections were raised by employees during the public announcement period regarding the proposed incentive recipients.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688293shanghai-opm-biosciences-co-ltdreview-opinion-and-statement-on-the-public-disclosure-of-the-list-of-participants-for-the-reserved-grant-first-batch-under-the-companys-2026-restricted-share-and-share-appreciation-rights-incentive-plan-issued-by-the-remuneration-and-appraisal-committee-of-the-board-of-directors

Release

Review Opinion and Statement on the Public Disclosure of the List of Participants for the Reserved Grant (First Batch) under the Company's 2026 Restricted Share and Share Appreciation Rights Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shanghai OPM Biosciences Co., Ltd. on 6ix

Story so far

Earlier from Shanghai OPM Biosciences

Later from Shanghai OPM Biosciences

All Shanghai OPM Biosciences news releases